A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine

15 April 2022.

Hui Jing Yu, Eva Thijssen, Emilie van Brummelen, Johan L. van der Plas, Igor Radanovic, Matthijs Moerland, Eric Hsieh, Geert Jan Groeneveld, Jean-Cosme Dodart